Encompass Health Earnings & Forecasts

Encompass Health (EHC) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

분기별 실적 서프라이즈 금액

회계 분기	보고된 날짜	실제 EPS	예상 EPS	놀라다 %
Q2	Aug 5, 2026	$1.55	$1.48	4.73 %
Q1	Apr 30, 2026	$1.60	$1.50	6.67 %
Q4	Feb 5, 2026	$1.46	$1.30	12.3 %
Q3	Oct 29, 2025	$1.23	$1.19	3.36 %

Quarterly Revenue (Billions)

분기별 수익 깜짝 금액

회계 분기	보고된 날짜	실제 수익	예상 수익	놀라다 %
Q2	Aug 5, 2026	$1.60B	$1.57B	1.59 %
Q1	Apr 30, 2026	$1.59B	$1.57B	1.14 %
Q4	Feb 5, 2026	$1.55B	$1.54B	0.34 %
Q3	Oct 29, 2025	$1.48B	$1.48B	-0.16 %

Encompass Health Guidance

Encompass Health (EHC)은 지난 8월 5, 2026에 fiscal year 2026의 실적 전망을 발표했습니다. 회사는 주당순이익을 $6.02 - $6.25 범위로 전망했으며, 이는 시장 컨센서스 EPS 추정치인 $6보다 높은 수치입니다. Encompass Health는 또한 해당 기간의 매출을 $6.41B - $6.49B 범위로 전망했습니다.

이전 가이던스와 비교하여 Encompass Health는 주당순이익(EPS) 전망치를 이전 범위인 상향 조정됨에서 $5.89 - $6.11로 상향 조정했습니다. 매출 측면에서는 회사가 매출 전망치를 이전 범위인 유지됨에서 $6.38B - $6.47B로 상향 조정했습니다.

Encompass Health은 20과 10월 26, 2022 사이에 8월 5, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 14 times, reflecting management's growing confidence in business performance.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$1.48	$1.50	$1.30	$1.19
Actual	$1.55	$1.60	$1.46	$1.23
Surprise	+4.73%	+6.67%	+12.3%	+3.36%
Revenue
Estimate	$1.57B	$1.57B	$1.54B	$1.48B
Actual	$1.60B	$1.59B	$1.54B	$1.48B
Surprise	+1.59%	+1.14%	+0.34%	-0.16%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$1.36	$1.60	$1.70	$1.69
Revenue
Consensus	$1.60B	$1.67B	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

PRO
Encompass Health Raises FY2026 Adj EPS Guidance from $5.89-$6.11 to $6.02-$6.25 vs $6.00 Est; Raises FY2026 Sales Guidance from $6.375B-$6.470B to $6.410B-$6.490B vs $6.421B Est

Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $5.89-$6.11 to $6.02-$6.25 vs $6.00 analyst estimate. Raises FY2026 sales outlook from $6.375 billion-$6.470 billion to $6.410 billion-$6.490 billion vs

Benzinga Newsdesk

PRO
Encompass Health Q2 Adj. EPS $1.55 Beats $1.48 Estimate, Sales $1.597B Beat $1.571B Estimate

Encompass Health (NYSE:EHC) reported quarterly earnings of $1.55 per share which beat the analyst consensus estimate of $1.48 by 4.73 percent. This is a 10.71 percent increase over earnings of $1.40 per share from the

Benzinga Newsdesk

PRO
Encompass Health Raises FY2026 Adj EPS Guidance from $5.81-$6.10 to $5.89-$6.11 vs $6.00 Est; Raises FY2026 Sales Guidance from $6.365B-$6.465B to $6.375B-$6.470B vs $6.423B Est

Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $5.81-$6.10 to $5.89-$6.11 vs $6.00 analyst estimate. Raises FY2026 sales outlook from $6.365 billion-$6.465 billion to $6.375 billion-$6.470 billion vs

Benzinga Newsdesk

Encompass Health Corp